Alglucosidase alfa demonstrates effectiveness and safety in Chinese patients with late-onset Pompe disease: A multi-center prospective study

Authors:

Abstract
No abstract available
Funding Information
  • Sanofi
  • Sanofi China Investment Company

This publication has 20 references indexed in Scilit: